NCT03109626View on ClinicalTrials.gov

Docosahexaenoic Acid (DHA) Replacement for Treatment in Spinocerebellar Ataxia 38

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 17, 2015

Primary Completion Date

September 17, 2015

Study Completion Date

June 25, 2018

Conditions
SCA38
Interventions
DIETARY_SUPPLEMENT

DHA

Trial Locations (1)

25100

AO Spedali Civili, Brescia

All Listed Sponsors
lead

Barbara Borroni

OTHER

NCT03109626 - Docosahexaenoic Acid (DHA) Replacement for Treatment in Spinocerebellar Ataxia 38 | Biotech Hunter | Biotech Hunter